(NewsDirect)
Valeo Pharma CEO Steve Saviuk joined SteveDarling from Proactive to share details the company has entered into acredit facility agreement with Accord Financial for a total of $5million.
The credit facility,backed by a first-ranking lien on the company's short-term assets,carries interest at the prime rate plus an applicable margin. Thecapital secured through this facility will enable Valeo Pharma tosustain its rapid growth trajectory without resorting to sharedilution, safeguarding the interests of its shareholders.
Valeo Pharma is a dynamic Canadianpharmaceutical company with a dedicated focus on the commercializationof innovative prescription products in Canada. The company'semphasis on respiratory/allergy, ophthalmology, and hospital specialtyproducts underscores its commitment to delivering essential healthcaresolutions.
The credit facility is a strategic move thatpositions Valeo Pharma to continue its expansion efforts and meet therising demand for innovative pharmaceutical products while preservingthe value for its shareholders.
ContactDetails
Proactive Investors
+1 604-688-8158
na-editorial@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.